NEW YORK (GenomeWeb News) - Oxford Gene Technology has licensed patents covering its oligonucleotide array technology to NimbleGen, based in Madison, Wisc., the companies said today.
The companies have also signed a supply agreement under which OGT will have access to NimbleGen’s DNA microarrays for use in its services business. NimbleGen will also be able to make and sell OGT-designed arrays.
Financial terms of the agreements were not released.
This is the second agreement that NimbleGen has recently signed for fundamental array IP. In October, the company licensed the rights to Affymetrix’s microarray patents.